Conditions: Atrial Fibrillation Ablation
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 20
Healthy volunteers: no

Brief summary:
Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered every six hours with a 30 minute IV infusion time per dose, compared to matched placebo infusion

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Vitamin C intervention 2: Placebo
Intervention descriptions: intervention 1: 200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W intervention 2: 50mL infused over 30 minutes

Protocol document:
Prot_000.pdf: